Next Article in Journal / Special Issue
A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma
Previous Article in Journal
Mosaic Pattern of Lung Attenuation on Chest CT in Patients with Pulmonary Hypertension
Previous Article in Special Issue
Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent
Open AccessBrief Report

HBV Core Protein Enhances Cytokine Production

Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
*
Author to whom correspondence should be addressed.
Current Address: Department of General Surgery, First Hospital of Hebei Medical University, Shijiazhuang 050031, China.
Academic Editor: Stephen L. Chan
Diseases 2015, 3(3), 213-220; https://doi.org/10.3390/diseases3030213
Received: 30 July 2015 / Revised: 10 September 2015 / Accepted: 14 September 2015 / Published: 17 September 2015
(This article belongs to the Special Issue Targeted Therapy of Hepatocellular Carcinoma: Present and Future)
Hepatitis B virus (HBV) infection, a cause of hepatocellular carcinoma (HCC), remains a serious global health concern. HCC development and human hepatocarcinogenesis are associated with hepatic inflammation caused by host interferons and cytokines. This article focused on the association between the HBV core protein, which is one of the HBV-encoding proteins, and cytokine production. The HBV core protein induced the production of interferons and cytokines in human hepatoma cells and in a mouse model. These factors may be responsible for persistent HBV infection and hepatocarcinogenesis. Inhibitors of programmed death (PD)-1 and HBV core and therapeutic vaccines including HBV core might be useful for the treatment of patients with chronic HBV infection. Inhibitors of HBV core, which is important for hepatic inflammation, could be helpful in preventing the progression of liver diseases in HBV-infected patients. View Full-Text
Keywords: HBV; core; cytokine; interferon HBV; core; cytokine; interferon
Show Figures

Figure 1

MDPI and ACS Style

Kanda, T.; Wu, S.; Sasaki, R.; Nakamura, M.; Haga, Y.; Jiang, X.; Nakamoto, S.; Yokosuka, O. HBV Core Protein Enhances Cytokine Production. Diseases 2015, 3, 213-220.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop